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Abstract 
Background: High-throughput screening methods assume that the output measured is representative of changes 
in metabolic flux toward the desired product and is not affected by secondary phenotypes. However, metabolic engi-
neering can result in unintended phenotypes that may go unnoticed in initial screening. The red pigment lycopene, a 
carotenoid with antioxidant properties, has been used as a reporter of isoprenoid pathway flux in metabolic engineer-
ing for over a decade. Lycopene production is known to vary between wild-type Escherichia coli hosts, but the reasons 
behind this variation have never been fully elucidated.
Results: In an examination of six E. coli strains we observed that strains also differ in their capacity for increased 
lycopene production in response to metabolic engineering. A combination of genetic complementation, quantitative 
SWATH proteomics, and biochemical analysis in closely-related strains was used to examine the mechanistic reasons 
for variation in lycopene accumulation. This study revealed that rpoS, a gene previously identified in lycopene produc-
tion association studies, exerts its effect on lycopene accumulation not through modulation of pathway flux, but 
through alteration of cellular oxidative status. Specifically, absence of rpoS results in increased accumulation of reac-
tive oxygen species during late log and stationary phases. This change in cellular redox has no effect on isoprenoid 
pathway flux, despite the presence of oxygen-sensitive iron-sulphur cluster enzymes and the heavy redox require-
ments of the methylerythritol phosphate pathway. Instead, decreased cellular lycopene in the ΔrpoS strain is caused 
by degradation of lycopene in the presence of excess reactive oxygen species.
Conclusions: Our results demonstrate that lycopene is not a reliable indicator of isoprenoid pathway flux in the 
presence of oxidative stress, and suggest that caution should be exercised when using lycopene as a screening tool 
in genome-wide metabolic engineering studies. More extensive use of systems biology for strain analysis will help 
elucidate such unpredictable side-effects in metabolic engineering projects.
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Background
Engineering of microorganisms for the production of 
isoprenoid compounds continues to attract intensive 
research efforts due to the high value and versatility of 
this class of natural products for industrial applications 
[1, 2]. Much progress has been made in recent years 
towards heterologous production of these sought-after 
molecules via microbial fermentation processes [3, 4]. 
However, fundamental questions about the regulation of 
the metabolic pathways leading to the production of iso-
prenoids are still unresolved, particularly in the methyl-
erythritol-phosphate (MEP) pathway used by Escherichia 
coli [5, 6]. It is known that the ability to sustain heterolo-
gous isoprenoid production varies significantly between 
E. coli strains [7–10]. We speculate that understanding 
the molecular events that underpin this difference in 
capacity will, in turn, improve our understanding of the 
regulation of isoprenoid production.
Lycopene, a C40 carotenoid pigment, is widely used 
as a reporter of isoprenoid pathway flux. Due to its red 
color, differences in lycopene content can be estimated 
by visual inspection and quantified with a quick and 
inexpensive spectrophotometric method. This has led 
to lycopene becoming the metabolite of choice in high-
throughput metabolic engineering studies of isoprenoid 
pathway flux [11–18]. Lycopene has been used to identify 
rate-limiting steps of the MEP pathway [7], test in silico 
predictions of metabolic fluxes in a pathway engineering 
context [16], and, more recently, to demonstrate the fea-
sibility of improving a desired phenotype using multiplex 
automated genome engineering [11]. Importantly, several 
studies focused on identifying E. coli genes not directly 
involved in core MEP pathway reactions that affect lyco-
pene production [12, 14, 19, 20]. Differential expression 
of these non-MEP pathway genes was used to increase 
lycopene production, often without an in-depth analy-
sis of the mechanism leading to this phenotype. Implic-
itly, these association studies inferred a link between 
the identified overexpression- or knockout targets and 
changes in carbon flux towards lycopene.
Despite more than twenty non-MEP pathway genes 
having been associated with variation in lycopene pro-
duction, it remains unclear whether changes in pigment 
accumulation are in fact related to flux through the iso-
prenoid pathway. The purpose of this study was to under-
stand the effect of non-MEP pathway genetic factors on 
the production of lycopene in E. coli, and whether or not 
they influence MEP pathway flux.
In this study, a pair of genetically near-identical E. coli 
strains were identified that displayed a large difference in 
lycopene accumulation. By comparing E. coli with similar 
genetic backgrounds we aimed to understand the mecha-
nisms behind differences in lycopene production and 
MEP pathway flux between these strains. Here we use 
genomics, quantitative proteomics and metabolomics as 
well as probing intracellular reactive oxygen species to 
demonstrate that lycopene production phenotypes in E. 
coli are not necessarily linked to changes in pathway flux.
Results and discussion
Lycopene production varies between wild‑type 
and engineered E. coli strains
Significant variability in lycopene production between 
common laboratory strains of E. coli has been reported 
previously [7, 21]. We first explored this variability across 
phylogenetic groups (A and B1), between isolates (B and 
K-12) and between parental strains and derivatives cured 
of phages and plasmids (e.g., WG1 versus MG1655*) 
(Fig. 1a).
Significant variation in the capacity to produce lyco-
pene was observed between strains transformed with 
a lycopene production plasmid (Fig.  1b). A 12-fold dif-
ference was observed between the highest producer 
(Mach1, 0.38 ± 0.02 mg OD−1600) and the lowest producer 
(MG1655*, 0.03  ±  0.017  mg OD−1600). Large differences 
in lycopene production were also seen between closely 
related strains with the WG1 parental strain producing > 
sixfold more lycopene than its derivative, MG1655*. To 
test the hypothesis that growth rate affects lycopene pro-
duction, a fast-growing derivative of MG1655, Seq+ (also 
described as KRE10000) [22–24], was included in the 
analysis. Seq+ differs from the reference MG1655 strain 
by a single nucleotide polymorphism (SNP) in the rph 
gene. This mutation affects expression of the downstream 
pyrE gene involved in pyrimidine biosynthesis, leading 
to a pyrimidine starvation phenotype and slower growth 
in rph− strains such as MG1655. In Seq+ this mutation 
is repaired, therefore Seq+ has a slightly higher specific 
growth rate. The Seq+ strain produced lycopene at simi-
lar levels to the parental strain WG1 (Fig. 1b).
Variability in isoprenoid production under pathway 
engineering
Overexpression of deoxyxylulose-5-phosphate synthase 
(dxs) enhances production of lycopene (and several other 
isoprenoids, [6, 25]) in a variety of genetic backgrounds 
[14, 20, 26, 27], and Dxs is considered to be the rate-
limiting enzyme for isoprenoid production in E. coli [7, 
28]. In order to explore engineerability, all strains were 
co-transformed with a plasmid for overexpression of 
dxs (pT-dxs) as well as the lycopene production plas-
mid. All of the engineered strains accumulated more 
lycopene than their respective wild-types (Fig.  1b), but 
the degree to which lycopene production was increased 
by dxs overexpression differed greatly. The lowest 
increase in production was observed for E. coli BB (25 % 
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increase ±9.8 %) and the highest was observed for E. coli 
W (323 % increase ±17 %).
The greater engineerability of W strains is of great 
practical interest. However, the large genetic dissimilar-
ity between E. coli W and MG1655* [29], the best and 
worst lycopene producers (Fig. 1b), complicates a direct 
comparison between these two strains. Nevertheless, E. 
coli MG1655 is the most commonly used strain for iso-
prenoid production and its exceptionally low capacity to 
produce lycopene was noteworthy. We therefore focused 
on differences between strains in the K-12 lineage.
Complementation of rpoS, but not rph, increases lycopene 
accumulation
Genetic variability among different stocks of E. coli 
MG1655 is a recently recognized problem that can lead 
to inconsistent results between laboratories [30]. We 





































































































Fig. 1 Inter-strain variability in lycopene accumulation and dependence on RpoS. a Relationships between E. coli strains used in this study. b Lyco-
pene production in parental and derived laboratory strains from different phylogenetic groups. Production was measured either with the lycopene 
production plasmid (pAC-LYC04) plus empty vector plasmid (pTrc99SS), or with pAC-LYC04 and a dxs overexpression plasmid (pT-dxs). c Fermenta-
tion profile for lycopene production in a high (Seq+) and low (MG1655*) producer strain. Cells were grown in batch culture in 1 L bioreactors and 
samples for quantitative proteomics were collected in exponential, early and late stationary phase. d Functional complementation of the rpoS gene 
in the low producer MG1655* restores the lycopene production phenotype to high producer (Seq+) levels
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this study, identifying a number of previously described 
mutations common in MG1655-derivatives (Table  1). 
The only loss-of-function mutation that distinguished 
the low-producing MG1655* strain from the two high-
producing K-12 strains, Seq+ and WG1, was the frame 
shift in the rph gene in MG1655*. When this mutation 
was repaired in an rph− MAGE strain (Nuc5-.dnaG.
Q576A.tolC-, a strain optimized for facile genome edit-
ing), a slight increase in growth rate was observed; how-
ever, lycopene production was unaffected (see Additional 
file 1).
It has previously been demonstrated that the stationary 
phase sigma factor RpoS (or σS) and genes regulating its 
abundance positively affect lycopene production [14, 19, 
20, 31]. Our MG1655* isolate contains a premature stop 
codon in the rpoS gene, a commonly occurring mutation 
in laboratory E. coli strains assumed to arise as an adap-
tation to typical laboratory growth conditions [32]. Seq+ 
accumulates sevenfold more lycopene than MG1655*, 
and does not have the rpoS amber mutation (Table  1). 
Complementation with a functional copy of rpoS under 
its native promoter restored lycopene production in 
MG1655* (Fig. 1d). The rpoS knockout was thus identi-
fied as the single factor responsible for the decreased 
lycopene production in MG1655*.
Interestingly, strain WG1 was one of the highest pro-
ducers of the initial screen (Fig.  1b), and accumulates 
lycopene without a functional copy of rpoS (Table  1). 
Closer analysis of the WG1 genome, including the 34 
other detected in-frame SNPs and INDELs, should pro-
vide insight into potential compensation mechanisms in 
this strain. One possibility is a partial rescue of the rpoS+ 
phenotype in WG1 through a missense mutation in the 
primary sigma factor rpoD (Y571H) that is not present in 
MG1655*, particularly since condition-dependent com-
petition between these transcriptional regulators has 
been suggested recently [33]. Alternatively, WG1 might 
have other means to control cellular redox status (see 
below) that have been lost in MG1655*.
The role of RpoS in lycopene production
While the importance of RpoS had been identified pre-
viously and confirmed in the above experiments, its 
mechanism of action in regulating lycopene production 
remained unclear. A detailed time-course comparison 
between an rpoS+ high lycopene producer (Seq+) and a 
low-producing ΔrpoS strain (MG1655*) was carried out 
in order to test whether RpoS controls isoprenoid biosyn-
thesis through direct or indirect mechanisms. Direct con-
trol would imply that RpoS is responsible for increased 
concentration of MEP pathway or lycopene pathway 
enzymes in Seq+ compared to MG1655*. Transcriptom-
ics studies published elsewhere suggest that MEP path-
way transcription is not directly regulated by RpoS [33]. 
Therefore, RpoS might exert flux control indirectly by 
affecting cellular metabolism in a way that favors lyco-
pene production, particularly since lycopene accumula-
tion occurs mostly during stationary phase (Fig. 1c). For 
example, RpoS may be required for providing sufficient 
redox equivalents, maturation systems for MEP path-
way enzymes, or removing competition for precursors 
from other pathways through protein degradation. These 
effects could not be examined using transcriptomics 
alone.
SWATH proteomics [34] was therefore used to quan-
tify global differences in the proteome of E. coli MG1655* 
and Seq+ during lycopene production (Fig. 1c). Approxi-
mately 43 % of the total expressed proteome of E. coli [35] 
was quantified at three time points during the fermenta-
tion (1126 proteins with at least three peptides detected 
were quantified, from a total of 1759 proteins with at 
least one peptide detected). Due to the low abundance 
of MEP pathway proteins, only five of the eight path-
way enzymes could be quantified using this approach; 
Table 1 Genomic variation in the E. coli K-12 strains used in this study
a CGSC#: 7740, reference genome NC_000913.3
b CGSC#: 5073, not all identified mutations are listed here
Gene Position Type Effect MG1655a reference WG1b MG1655* Seq+
rpoS 2865477 SNP STOP C T T C
yedY 2038457 SNP Missense C A A C
ycnA 1335418 SNP Missense A G G A
yfcS 1169059 SNP Missense T C C T
lamB 4246613 Insertion unknown C C IS2 C
crl 257899 Insertion Frame shift IS1 No insertion No insertion IS1
gatABC 2171384 Deletion Loss of operon – Deletion Deletion –
glpR 3558477 Deletion Frame shift – No FS No FS –
rph 3813902 Insertion Frame shift – G – G
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therefore, targeted selected reaction monitoring (SRM) 
methods were developed for quantification of all MEP 
and lycopene pathway enzymes.
Concentrations of MEP and lycopene pathway enzymes are 
not affected by RpoS
All of the MEP pathway enzymes were present at similar 
levels in the rpoS+ (Seq+) and rpoS− (MG1655*) strains 
(Fig. 2a, b). This is consistent with the lack of transcrip-
tional effects published previously [33]. Expression of 
enzymes from the pAC-LYC04 plasmid was also com-
parable in the two strains, indicating that this was not 
the source of variation either. We could thus rule out 
the hypothesis that RpoS affects lycopene production 
through direct regulation of pathway capacity by means 
of influencing transcription, translation or protein degra-
dation of MEP pathway or lycopene pathway enzymes.
Knockout of rpoS increases oxidative stress in stationary 
phase
The protein expression pattern was very similar during 
early and late stationary phase (Additional file 2) and data 
from these two time points were combined to enhance 
the statistical power and determine all differentially 
expressed proteins in the lycopene production phase. 
During lycopene production, 148 proteins were differen-
tially expressed in the ΔrpoS strain MG1655* (false dis-
covery rate < 0.05; see “Methods” for details on statistical 
analysis). Gene set enrichment analysis (GSEA) revealed 
that these can be grouped into five main categories: (1) 
chemotaxis, (2) galactitol metabolism, (3) C3 metabo-
lism, particularly involving glycerol and pyruvate, (4) aer-
obic respiration and (5) TCA cycle (Fig. 2c) (Additional 
file 3). Induction of genes for chemotaxis and motility is 
known to be under complex regulatory control of alterna-
tive sigma factors including RpoS [36] and was assumed 
to have no effect on lycopene production in a bioreac-
tor. The gat operon required for utilization of the alter-
native carbon source galactitol is deleted in MG1655* 
(Table 1). Proteins involved in galactitol metabolism were 
also assumed to have no significant effect in LB medium 
where catabolizable amino acids, not sugars, comprise 
the main carbon source [37] while galactitol is absent.
In contrast to the chemotaxis and galactitol proteins, 
the remaining GSEA groups—which are related to cen-
tral carbon metabolism (CCM) and cellular redox state—
present interesting targets for further examination. The 
concentration of proteins involved in C3 metabolism was 
decreased in MG1655*, whereas proteins involved in aer-
obic respiration and the TCA cycle were increased when 
compared to Seq+ (Fig. 2c). RpoS, the key regulator of the 
general stress response in E. coli, allows cells to adapt to 
various sub-optimal growth conditions—including lack 
of carbon source. As cells enter stationary phase, central 
carbon metabolism is rearranged and respiratory activ-
ity is reduced. The expression of TCA cycle and respira-
tory enzymes is down-regulated, presumably to prevent 
uncontrolled carbon draining and as a defense against 
accumulation of reactive oxygen species (ROS) produced 
during respiration (reviewed in [38]). Without RpoS, this 
mechanism is disabled in MG1655* and therefore TCA 
cycle and respiratory enzyme concentrations remain high 
in stationary phase.
Significant differences were also observed in the con-
centration of individual stress-response proteins. The 
concentration of the stationary phase-specific catalase 
KatE (HPII), which is part of the RpoS sigmulon [39], 
was reduced >twofold in MG1655* (Additional file 3). On 
the other hand, a 1.5-fold increase was observed for the 
manganese-dependent superoxide dismutase, SodA. The 
expression of sodA is RpoS-independent, but it is induced 
in response to oxidative stress [40]. Taken together, these 
results suggested a compensatory response to elevated 
levels of reactive oxygen species (ROS) in MG1655*. The 
H2O2-activated fluorescent dye dihydrorhodamine 123 
was therefore used to examine ROS levels during differ-
ent growth phases. Indeed, a significant increase of intra-
cellular H2O2 was detected in MG1655* compared to 
Seq+ during the transition from exponential to stationary 
phase growth (Fig. 3), confirming that higher concentra-
tions of ROS accumulate in MG1655* in the absence of 
RpoS.
Knockout of rpoS does not influence flux through the MEP 
pathway
Despite the abundance of MEP and lycopene pathway 
enzymes being comparable in both strains, lycopene was 
barely detectable in MG1655*. Two of these enzymes, 
the iron sulphur cluster-containing proteins IspG and 
IspH are sensitive to oxygen levels [41]. Activity of these 
enzymes may therefore be decreased by high levels of 
oxidative stress. In the event of partial IspG or IspH inac-
tivation, an accumulation of MEP pathway intermediates 
could be expected in MG1655*. In particular, methyl-
erythritol cyclodiphosphate (MEcPP), the substrate for 
ispG, has been shown to accumulate to high concen-
trations under a range of conditions [42, 43]. However, 
analysis of MEP pathway metabolites during lycopene 
production showed that MEcPP did not accumulate 
in MG1655*; in fact, the intracellular concentration of 
MEcPP was slightly greater in Seq+ at 4 h post-induction 
(Fig.  4a). At this time point, the level of other interme-
diates both upstream (MEP and CDP-ME) and down-
stream (HMBPP, IPP/DMAPP and FPP) of MEcPP were 
higher in MG1655*, suggesting that—if anything—lyco-
pene accumulation should be greater.






























































































































































Fig. 2 Quantitative proteomics comparison of Seq+ and MG1655* during lycopene production. a Selective Reaction Monitoring (SRM) prot-
eomics for all MEP and lycopene production pathway enzymes measured in this study. b Lycopene biosynthesis pathway in E. coli. Shown are all 
enzymes involved in the formation of lycopene from glyceraldehyde-3-phosphate (GA3P) and pyruvate (PYR), as well as reactions competing for 
either isopentenyl pyrophosphate (IPP), dimethylallyl-pyrophosphate (DMAPP) or farnesyl-pyrophosphate (FPP). Peptides for MiaA and IspU were 
obtained but did not match our quality criteria and were excluded from this study. c Gene Set Enrichment Analysis of differentially expressed genes 
in the lycopene production phase. Up- or down-regulated proteins are shown for the ΔrpoS strain MG1655* relative to Seq+. Abbreviations: MEP 
pathway: Dxs, 1-deoxyxylulose-5-phosphate synthase; Dxr, 1-deoxy-d-xylulose-5-phosphate reductoisomerasease; IspD, 4-diphosphocytidyl-2-C-
methyl-d-erythritol synthase; IspE, 4-diphosphocytidyl-2-C-methyl-d-erythritol kinase; IspF, 2-C-methyl-d-erythritol 2,4-cyclodiphosphate synthase; 
IspG, 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate synthase; IspH, hydroxymethylbutenyl diphosphate reductase; Idi, isopentenyl diphosphate 
isomerase. Competing pathways: IspA, farnesyl pyrophosphate synthase; IspB, octaprenyl diphosphate synthase; IspU, undecaprenyl diphosphate 
synthase; MiaA, tRNA(i6A37) synthase. pAC-LYC04: Idi(pLYC) from H. pluvialis; CrtE, geranylgeranyl diphosphate synthase from P. agglomerans; CrtB, 
phytoene synthase from P. agglomerans; CrtI, phytoene desaturase from P. agglomerans
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As an alternative measure of MEP pathway flux, iso-
prene production was examined in the two strains. 
Isoprene synthase uses DMAPP as a substrate, thus repre-
senting an immediate read-out of carbon flux through the 
MEP pathway. When a heterologous isoprene synthase 
was overexpressed, there was no significant difference 
in isoprene production between Seq+ and MG1655* 
(Fig. 4b). This result further confirmed that MEP pathway 
flux was unaffected by oxidative stress in MG1655* and 
indicated a lycopene-specific effect of the rpoS knockout.





Fig. 3 rpoS knockout causes oxidative stress in stationary phase. Cells were grown in the presence of the H2O2-activated fluorescent dye DHR123 
and subjected to flow cytometry to measure intracellular ROS. Peaks represent distribution of fluorescence intensity from ten thousand cells per 










































































Fig. 4 MEP pathway flux is not affected by RpoS. a Intracellular MEP pathway metabolite pools during lycopene production in MG1655* and Seq+ 
with dxs overexpression. Glyceraldehyde-3phosphate (GA3P), dihydroxyacetone-phosphate (DHAP), pyruvate (PYR), 1-deoxy-d-xylulose 5-phos-
phate (DXP), 2-C-methyl-d-erythritol-4-phosphate (MEP), 4-diphosphocytidyl-2-C-methylerythritol (CDP-ME), 2-C-methyl-d-erythritol-2,4-cyclodi-
phosphate (MEcPP), (E)-4-Hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP), isopentenyl pyrophosphate (IPP)/dimethylallyl pyrophosphate 
(DMAPP; no chromatographic separation of IPP and DMAPP) and farnesyl pyrophosphate (FPP) were quantified using liquid chromatography tan-
dem mass spectrometry (LC–MS/MS). 4-Diphosphocytidyl-2-C-methyl-d-erythritol-2-phosphate (CDP-MEP) was below detection level in all samples. 
b Isoprene production in the two strains harboring pT-ispS(L70R)
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Oxidative stress decreases ‘measurable’ lycopene
Lycopene is a potent antioxidant, and is used by many 
plant species as a scavenger for reactive oxygen species 
(reviewed in [44]). The chromogenic conjugated double 
bonds of lycopene are readily oxidized, leading to loss 
of the characteristic red color and the formation of vari-
ous colorless oxidation and cleavage products [45, 46]. 
The commonly used assay for lycopene quantification in 
E. coli is based on a spectrometric measurement of cell 
extracts at 472–475 nm, the lycopene-specific absorption 
maximum [7]. Therefore this assay quantifies only intact, 
fully conjugated lycopene molecules.
We hypothesized that the apparent differences in lyco-
pene production between Seq+ and MG1655* strains 
may in fact be due to lycopene degradation in the pres-
ence of increased levels of ROS in MG1655*. In stationary 
phase, when the majority of lycopene production occurs 
(Fig. 1c), the catalase KatE serves as the primary scaven-
ger of H2O2. Expression of KatE is RpoS-dependent, and 
our proteomics results show that it was decreased two-
fold in MG1655* (Additional file 2). When grown on solid 
medium, overexpression of katE increased measurable 
lycopene in MG1655*, reducing the difference between 
Seq+ and MG1655* to less than two-fold from previously 
eightfold (Fig. 5a). This effect was not observed in liquid 
culture, suggesting further interplay between KatE and 
other factors in regulating oxidative stress under different 
growth conditions.
We next tested whether measurable lycopene content 
could be decreased by high levels of intracellular ROS. 
Therefore, the high lycopene producer Seq+ was treated 
with menadione, which induces ROS formation in E. coli 
[47, 48]. The measurable lycopene content decreased sig-
nificantly in the presence of sublethal doses of menadione 
(Fig. 5b). Importantly, this phenotype was not a result of 
exogenous addition of ROS, but an effect of menadione-
induced redox cycling leading to intracellular ROS gener-
ation [49], thereby resembling the situation in MG1655* 
(Fig. 3).
Conclusions
We have carried out a systematic analysis of the vari-
ability in lycopene production phenotypes between 
different E. coli strains. We aimed to identify global regu-
lators of flux through the MEP pathway in E. coli using 
lycopene as a read-out. It was found that lycopene pro-
duction varies significantly in wild-type and engineered 
E. coli strains from different phylogenetic groups, and 
that strains respond differently to overexpression of the 
assumed primary rate-limiting enzyme Dxs. Our genom-
ics analyses confirmed the previously described impor-
tance of RpoS for high-level lycopene accumulation [14, 
20]; but we propose a new mechanism by which RpoS 
affects the lycopene production phenotype. RpoS has no 
effect on the abundance of any of the enzymes involved 
in lycopene biosynthesis. Furthermore, we demonstrate 
that knockout of rpoS does not affect the function of the 
iron-sulfur cluster proteins IspG or IspH, and in fact has 
no impact on MEP pathway flux under the conditions 
tested here. Instead, an excess of respiratory and TCA 
cycle activity combined with decreased expression of 
KatE (and possibly other ROS-scavenging enzymes) leads 
to oxidative stress in the ΔrpoS strain. We propose that 
















































Fig. 5 Excess reactive oxygen species decrease measurable lycopene content. a The stationary-phase specific catalase KatE was expressed under 
an arabinose-inducible promoter to complement katE expression in MG1655*. b Seq+ was grown in the presence of increasing concentrations of 
the redox cycling agent menadione. Values for Seq+ harboring pAC-LYC04 only, or in combination with pT-dxs, are shown on the right and left axis, 
respectively. The inlet shows cell pellets at the end of the fermentation with the increasing concentrations of menadione
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lycopene in producing E. coli cells by degrading the pig-
ment to its colorless oxidation- and cleavage products.
These findings have significant implications for the 
study of lycopene production in E. coli. Firstly, it dem-
onstrates that lycopene is not a suitable tool to study 
flux through isoprenoid pathways, for which it has 
been frequently used for nearly two decades [11–17]. 
Secondly, several studies that have identified genes 
‘involved in lycopene biosynthesis’ should be carefully 
re-evaluated with regard to our findings. RpoS itself was 
identified independently at least twice in these shotgun 
approaches [14, 20], and several other genes involved in 
regulating either RpoS-dependent gene expression, deg-
radation of RpoS, or stationary phase metabolism (crl, 
iraD, iraM and appY, respectively [13, 14, 20, 50]) were 
described to alter lycopene biosynthesis. While these 
genes may certainly be important for successful accu-
mulation of intact lycopene (and potentially other oxy-
gen-sensitive carotenoids) in E. coli, their role cannot be 
generalized to increasing flux towards lycopene or other 
isoprenoids. Some of the genes identified previously 
in associative studies most likely exert their effect on 
lycopene accumulation through a similar mechanism, 
and not through alteration of isoprenoid pathway flux. 
Therefore, we discourage the use lycopene and other 
carotenoids as reporter metabolites for isoprenoid pro-
duction. If these molecules are used, it is strongly rec-
ommended to monitor cellular oxidative status after 
performing genetic modifications or when characteriz-
ing a new lycopene production phenotype. Instead, we 
recommend the use of isoprene as a reporter of MEP 
pathway flux since it combines a number of advantages: 
(1) isoprene is directly produced from DMAPP, one of 
two final metabolites of the MEP pathway [51], (2) only 
one heterologous enzyme (isoprene synthase) must 
be introduced, reducing the likelihood of unexpected 
side-effects [52, 53], (3) the high volatility of isoprene 
ensures that the product leaves cells efficiently [54, 55], 
(4) unlike lycopene, which sequesters into the cell mem-
brane, isoprene has no known reactivity with E. coli 
metabolism or influence on cell growth. Isoprene has 
been widely used as a pathway reporter and industrial 
product in E. coli [56–59], the primary limitation being 
a lack of published inexpensive, high-throughput analy-
sis systems.
Accessing the potential of the MEP pathway would 
theoretically provide a route to achieve higher yields of 
isoprenoids than we can currently achieve using the 
MVA pathway. We have presented a set of metabolomics 
and proteomics tools enabling us to analyze differences 
in flux through the MEP pathway, and thus assess the 
true capacity of a strain to direct carbon towards these 
high-value compounds. Finding a production host that 
responds well to metabolic engineering of this pathway 
may prove essential. While we have focused on the MEP 
pathway in the current study, our findings regarding the 
suitability of lycopene as an isoprenoid pathway flux 
reporter are equally applicable to the MVA pathway.
Methods
Chemicals and reagents
Lycopene (Cat. No. L9879), isoprene (Cat. No. 
I19551), dihydrorhodamine 123 (DHR, Cat. No. 
D1054), tributylamine (≥99.0  %, Cat. No. 90780), 
menadione sodium bisulfite (Cat. No. M5750), glyc-
eraldehyde-3-phosphate (Cat. No. G5251), dihydroxy-
acetone-phosphate (Cat. No. D7137) and pyruvate 
(Cat. No. P2256) were purchased from Sigma-Aldrich 
(St. Louis, MO, USA). 1-Deoxy-d-xylulose 5-phos-
phate  (DXP), 2-C-methyl-d-erythritol-4-phosphate 
(MEP), 4-diphosphocytidyl-2-C-methylerythritol (CDP-
ME), 4-diphosphocytidyl-2-C-methyl-d-erythritol 
2-phosphate (CDP-MEP, synthesis kit), 2-C-methyl-
d-erythritol-2,4-cyclodiphosphate (MEcPP), (E)-4-Hy-
droxy-3-methyl-but-2-enyl pyrophosphate (HMBPP), 
isopentenyl pyrophosphate (IPP), dimethylallyl pyroph-
osphate (DMAPP) and farnesyl pyrophosphate (FPP) 
were purchased from Echelon Biosciences (Salt Lake 
City, UT, USA). Isopropyl-B-D-1-thiogalactopyranoside 
(IPTG, Cat. No. AST0487) was purchased from Astral 
Scientific (Taren Point, NSW, Australia). HPLC grade 
acetonitrile and acetic acid (AR Grade) were purchased 
from RCI Labscan (Bangkok, Thailand) and Labscan (Gli-
wice, Poland), respectively. Oligonucleotides were pur-
chased from Integrated DNA Technologies (Singapore). 
Trypsin (Trypsin Gold, Mass Spectrometry Grade) was 
purchased from Promega (NSW, Australia).
Gene, plasmid, and strain construction
All E. coli strains and plasmids used in this study are 
listed in Table 2. Reference numbers are provided where 
strains were obtained from the Coli Genetic Stock Center 
(CGSC), American Type Culture Collection (ATCC), 
or Addgene. All oligonucleotides used in this study are 
listed in Table 3.
The rph− mutation was repaired in an MG1655-
derived strain suitable for ssDNA recombineering, E. 
coli MG1655 ΔmutS::cat Δ(ybhB-bioAB)::[λcI857 N(cro-
ea59)::tetR-bla] xonA-, recJ-,xseA-, exoX- and redα- 
dnaG.Q576A tolC- [60]. The strain was obtained from 
Addgene (https://www.addgene.org, strain #41699). 
Co-selection multiplex automated genome engineer-
ing (MAGE) was performed as described previously 
[61]. Briefly, 4 rounds of MAGE were performed using 
the oligonucleotide rph repair (Table  2) to repair the 
rph- mutation; co-selection for ampicillin sensitivity was 
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performed using the ΔbioA::bla mut oligo described in 
[62]. Mutation of the rph locus was confirmed by Sanger 
sequencing (Table 3).
The sequence for the Populus trichocarpa dxs gene was 
obtained from the published genome sequence (http://
www.phytozome.net/poplar). Prediction of the chloro-
plast transit peptide was performed using the ChloroP 
1.1 server (http://www.cbs.dtu.dk/services/ChloroP/). E. 
coli codon optimization and synthesis of this truncated 
(transit peptide removed) sequence was performed by 
Genscript (Piscataway, NJ, USA). The dxs sequence was 
amplified from the plasmid vector provided by Gen-
script using oligonucleotides PEF-F02 and PEF-R02 
and sub-cloned at the University of Queensland Pro-
tein Expression Facility (St Lucia, QLD, Australia) into 
the pTispS(P.t.) plasmid, replacing the ispS(P.t.) gene. 
pTispS(P.t.) is pTrc99a plasmid harboring a truncated 
isoprene synthase gene from Populus trichocarpa, and 
was a gift from Professor Seon-Won Kim, Gyeongsang 
National University, Korea.
An isoprene synthase gene from Populus alba (Gen-
bank accession number EF638224) [63] was truncated 
as described previously [51] to remove the transit pep-
tide. In addition, an L70R mutation, which improves the 
specific activity of the enzyme [64] was introduced. E. 
coli codon optimization and synthesis of this truncated 
sequence was performed by Genscript. The plasmid pT-
ispS(L70R) was generated by replacing the ispS(P.t.) gene 
in pTispS(P.t.) with the ispS(L70R) gene, using primers 
PEF-F04 and PEF-R04.
Plasmid pRpoS was generated by amplifying the rpoS 
gene, including its core promoter (686  bp upstream of 
the start codon), from E. coli MG1655 using the oligo-
nucleotides rpoS-fw and rpoS-rev. Isothermal assembly 
Table 2 Escherichia coli strains and plasmids used in this study
Strain/plasmid Relevant characteristics References
E. coli WG1 E. coli K-12 wild type strain CGSC#: 5073
E. coli MG1655 F-, λ-, rph-1 CGSC#: 7740
E. coli MG1655* F-, λ−, rph-1, rpoS396(Am), see Table 1 CGSC#: 7740/this study
E. coli MG-rph+ MG1655-derivative Nuc5−.dnaG.Q576A, rph+ [60]/this study
E. coli Seq+ (KRE10000) MG1655 rph+ Obtained from Donald Court, [23, 75]
E. coli BB E.coli B wild type strain CGSC#: 2507
E. coli REL606 F-, tsx-467 (Am), araA230, lon, rpsL227 (strR), hsdR-, [mal+]K-12 (λ
S) CGSC#: 12149
E. coli W E.coli W wild type strain ATCC: 9637 [29]
E. coli Mach1 Commercially available cloning host derived from E. coli W Invitrogen™
E. coli Nuc5.dnaG.Q576A.tolC- MG1655-derived MAGE strain used for markerless genome engineering [76], Addgene strain #41699
pAC-LYC04 cat, idi from H. pluvialis, crtEIB from P. agglomerans [77]
pTrc99SS bla, Ptrc, truncated MCS (derived from pTrc99a) [78]/this study
pT-dxs bla, Ptrc, optimized dxs from P. trichocarpa This study
pT-ispS (L70R) bla, Ptrc, optimized ispS from P. alba This study
pRpoS kan, PrpoS, rpoS from MG1655 (derived from pET28a) This study
pAra-KatE bla, ParaBAD, katE from E. coli MG1655 (derived from pKD46) This study/[79]
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[65] was performed to insert the PrpoS-rpoS construct 
into a pET28a backbone, replacing the T7 promoter and 
His-tag from the vector.
Plasmid pAra-katE was generated by amplifying the 
katE ORF from E. coli MG1655 and cloning it into the 
backbone of pKD46 [8] under control of the araBAD pro-
moter. The lambda Red gene operon was replaced with 
the katE gene using isothermal assembly with the oligo-
nucleotides katE-fw and katE-rev.
Medium and growth conditions
All experiments described in this study were carried out 
with three biological replicates. All data are presented as 
mean ± standard deviation, unless stated otherwise.
Shake flask fermentations
All fermentations for lycopene production were per-
formed in shake flasks unless stated otherwise. Strains 
were grown in Luria–Bertani (LB) medium [66] con-
taining 34  μg chloramphenicol/ml to select for mainte-
nance of the pAC-LYC04 plasmid. 100 µg ampicillin/ml 
was used to maintain plasmids pT-dxs or pAra-katE; and 
50 µg kanamycin/ml for pRpoS. Pre-cultures were started 
from a single colony in 5 ml medium and were grown to 
stationary phase. A 1:100 dilution was used to inoculate 
50  ml of fresh medium as the main culture. Cells were 
grown in unbaffled 250  ml flasks at 30  °C and 250  rpm 
orbital shaking.
Fermentation in bioreactors for proteomics sampling
For experiments in bioreactors, cells were cultivated 
as in “Shake flask fermentations”, but the 50  ml shake 
flask culture was grown to mid-exponential phase 
(OD600 ≈  1) and then used to inoculate 200  ml of the 
same medium to a starting OD600 of 0.05. Cells were 
grown in a parallel bioreactor system (DasGip, Juelich, 
Germany) at 30  °C, pH was maintained at 6.9 by addi-
tion of 4 N NaOH, and dissolved oxygen (DO) was mon-
itored by an external DO meter (Presens, Regensburg, 
Germany) and maintained at 80 % of air saturation. At 
an OD600 of 0.5, lycopene production was induced with 
0.5 mM IPTG.
Lycopene production on solid media
For measurement of lycopene production after comple-
mentation with pAra-KatE, cells were transformed with 
the plasmid and grown O/N at 37  °C on LB agar plates 
containing 100  µg ampicillin/ml. They were incubated 
at room temperature for another 48 h before 3 colonies 
each were scraped from the plate, resuspended in 1 ml of 
H2O each and optical density and lycopene content were 
measured as described below.
Analytics
Lycopene production assay
Production of lycopene was quantified as described 
previously [55]. Briefly, after measurement of the opti-
cal density (OD600), biomass from 1  ml of culture was 
extracted with 1  ml of acetone at the indicated time 
points. Lycopene absorption was measured at 475  nm 
and values were normalized by OD600.
Isoprene production
Isoprene production was measured as described pre-
viously [55]. Single colonies of E. coli Seq+ or E. coli 
MG1655* bearing pT-ispS(L70R) were used to inocu-
late 2 ml precultures in LB medium and grown at 37 °C 
until stationary phase was reached. Cells were diluted 
1:100 into terrific broth (TB) with ampicillin, grown to 
an OD600 of 0.5, induced with 1  mM IPTG and grown 
for another 1.5 h at 30  °C. The culture was diluted 1:20 
into 500 µl of fresh induction medium (TB [67] contain-
ing 100 µg ampicillin/ml and 1 mM IPTG) and grown in 
sealed 20 ml gas chromatography (GC) vials (Agilent Cat. 
No. 5188-2753 and 5188-2759) for 48 h at 30 °C. Isoprene 
production was quantified directly from the culture 
headspace as described in [55].
Metabolite measurements
Intracellular metabolites were quenched and extracted 
using a method adapted from [43]: At the indicated time 
points, the equivalent of 2 OD600 (*ml) of culture were 
centrifuged at 4 °C for 20 s at 16,000×g, the supernatant 
was discarded and the pellet snap-frozen in liquid nitro-
gen. The pellet was resuspended in 300 µl of 80 % MeOH 
(v/v) and metabolites were extracted by vortexing for 
10 min at room temperature. Cell debris was removed by 
centrifugation at 4  °C for 15 min at 18,000×g. The sam-
ples were dried in a vacuum concentrator until the vol-
ume was <10 µl and then resuspended in ultrapure H2O 
to a final volume of 50 µl. One microliter of 0.5 mM AZT 
was added as an internal standard.
Liquid chromatography tandem mass spectrometry 
(LC–MS/MS) data were acquired on a Dionex UltiMate 
3000 liquid chromatography system (Dionex, Califor-
nia, USA) coupled to an ABSciex 4000 QTRAP mass 
spectrometer (ABSciex, Concord, Canada). The liquid 
chromatography system was controlled by Chromeleon 
software (v6.80 SR9, Dionex), and chromatographic sepa-
ration was achieved by injecting 10 μL onto a Gemini-NX 
C18 150 mm × 2 mm I.D., 3 μm 110 Å particle column 
(Phenomenex, Aschaffenburg, Germany) equipped 
with a pre-column Security Guard Gemini-NX C18 
4 mm × 2 mm I.D. cartridge. The column oven tempera-
ture was controlled and maintained at 55 °C throughout 
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the acquisition and the mobile phases (adapted from 
[68]) were as follows: 7.5  mM aqueous tributylamine 
adjusted to pH 4.95 (±0.05) with glacial acetic acid (elu-
ent A) and acetonitrile (eluent B). The mobile phase flow 
rate was maintained at 300 μL/min throughout the fol-
lowing elution profile composed of eluent A and B: 100 % 
eluent A decreased to 85  % eluent A over 10  min, then 
decreased to 70 % eluent A over 25 min, then decreased 
to 30 % eluent A over 10 min, then decreased to 0 % elu-
ent A over 2 min and held at 0 % eluent A for a further 
2  min, then increased to 100  % over 1  min and held at 
100 % A for 10 min. The gradient profile was introduced 
directly into the mass spectrometer with no split.
The mass spectrometer was controlled by Analyst 1.5.2 
software (ABSciex) and was equipped with a TurboV 
electrospray source operated in negative ion mode. The 
following optimized parameters were used to acquire 
scheduled Multiple Reaction Monitoring (MRM) data: 
ionspray voltage −4500  V, nebulizer (GS1), auxiliary 
(GS2), curtain (CUR) and collision (CAD) gases were 
60, 60, 20 and medium (arbitrary units), respectively. 
The auxiliary gas temperature was maintained at 350 °C. 
The analyte-dependent parameters for the detection of 
MEP pathway-related metabolites are given in Additional 
file 2. For all analytes the entrance potential (EP) was −10 
volts.
The samples were run with sample- and analyte-rele-
vant calibration standards and pooled QC samples [69, 
70] to control for reproducibility of data acquisition and 
to ensure data integrity. Analyte stock solutions were 
prepared in purified water (Veolia) and aliquots of each 
solution were mixed to achieve a final calibrant solu-
tion at 50 μM. This calibrant solution was serially diluted 
and the dilutions used as calibration standards from 50 
to 0.195 μM, constituting 5 ≤ x ≤ 9 calibration points to 
account for differential responses in the mass spectrom-
eter. Data were processed using MultiQuant 2.1 software 
(ABSciex).
Proteomics
SWATH and SRM sample preparation
Cell pellets for protein extraction were prepared in the 
same way as for metabolite extraction, see “Metabolite 
measurements”. Protein extraction and preparation for 
SWATH or targeted proteomics was performed using a 
method adapted from [71]: the frozen cell pellets were 
resuspended in 90 µl lysis buffer (50 mM Tris/HCl buffer, 
1 mM EDTA, pH 7.5) containing 2 mg lysozyme/ml. Cell 
wall lysis was performed at 37  °C for 15 min. DNA and 
RNA were digested by incubation with DNase and RNase 
(2 U each) for an additional 10 min. For the solubilization 
of membrane proteins, 10 µl of 10 % SDS (w/v) was added 
and samples were incubated at 37  °C under vigorous 
shaking for 15  min. Cell debris was removed via cen-
trifugation at 3345×g for 5 min and the supernatant was 
transferred and centrifuged at 11,300×g for 10 min. The 
crude protein extract was methanol/chloroform precipi-
tated as described previously [72]. Protein precipitates 
were redissolved in 100  µl denaturation buffer contain-
ing 8 M urea in 10 mM Tris buffer. Protein concentration 
was measured against a BSA standard curve using the 
BCA assay (Pierce™ Cat. No. 23227, Thermo Fischer Sci-
entific (VIC, Australia) according to the manufacturer’s 
instructions. Proteins were reduced with 1  mM dithi-
othreitol for 1 h at room temperature and then alkylated 
with 1 mM iodoacetamide (IAA) for 1 h at room temper-
ature in the dark. Samples were diluted to <1 M urea with 
900 µl 20 mM ammonium bicarbonate and digested with 
trypsin (1:50 w/w) O/N at 37 °C. Peptides were desalted 
using a Sep-Pak C18 cartridge (Waters, WAT054955) and 
eluted in 300  µl 70  % (v/v) acetonitrile, 0.1  % (v/v) trif-
luoric acid. Samples were dried in a vacuum concentrator 
and resuspended in 50 µl 0.1 % formic acid.
SWATH library reference and sample preparation
For SWATH peptide reference library generation, pep-
tides from all biological samples (ca. 300  µg total) were 
pooled and separated using SCX chromatography-based 
fractionation as described previously [73]. Briefly, pep-
tides were separated using a Zorbax 300-SCX column 
(5  µm, 4.6  ×  50  mm) (Agilent) at 0.5  ml  min−1 on an 
Agilent 1100 chromatography system. Fractions (250 µl) 
were collected in a microtitre plate and then pooled to 
give 12 fractions in total. C18 ZipTips (Millipore, Cat. No. 
ZTC18S096) were used for desalting. The SWATH refer-
ence library was generated from information-dependent 
acquisition (IDA) using the 12 fractions. The HRM Cali-
bration Kit (Ki-3003) from Biognosys (Schlieren, Swit-
zerland) was used as a retention time standard in all IDA 
and SWATH proteomics experiments. IDA and SWATH 
samples were injected twice (technical replicates) from 
5 µg of peptides and from 0.5 µg of peptides, respectively.
LC–MS/MS analysis of SWATH samples
IDA and SWATH samples were separated on a Shimadzu 
Prominence nanoLC system as described previously 
[74], Briefly, peptides were separated on a Vydac Ever-
est C18 (300 Å, 5 µm, 150 mm × 150 µm) column at a 
1 µl/min flow rate, using a gradient of 10–60 % buffer B 
over 75 min, where buffer A =  1 % ACN/0.1 % FA and 
buffer B  =  80  % ACN/0.1  % FA. Eluted peptides were 
directly analyzed on a Triple-TOF 5600 mass spectrom-
eter (ABSciex) equipped with a Nanospray III interface. 
SWATH analyses were scanned across m/z 350–1800 for 
0.05 s followed by high sensitivity DIA mode, using 26 Da 
(1  Da for window overlap) isolation windows for 0.1  s, 
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across m/z 400–1250. Collision energy for SWATH sam-
ples was automatically assigned based on m/z mass win-
dows by Analyst software.
SRM targeted proteomics
For method development, proteotypic peptides were syn-
thesized for each of the following E. coli MG1655 pro-
teins: Dxs, Dxr, IspD, IspE, IspF, IspG, IspH, Idi, IspA, 
IspB, IspU, MiaA, RpoS; as well as the proteins encoded 
on the pAC-LYC04 plasmid: Idi (H.p.), crtI (P.a.), CrtE 
(P.a.) and CrtB (P.a.). All peptides were synthesized by 
JPT (Berlin, Germany) as light SpikeTides™, dissolved 
according to manufacturer’s instructions and used to 
determine peptide retention times, dominant precursor 
and fragment ion masses. The top 5 fragment ions were 
selected for collision energy optimization. The three most 
intense fragment ions after optimization were used for 
the spectral library and later relative quantification of 
biological samples.
ESI based UPLC–MS/MS analyses were performed 
using a Shimadzu Prominence nano U-HPLC. Peptides 
were separated on an Aeris PEPTIDE XB-C18 Phenom-
enex column (1.7 μm 100 × 2.1 mm) at a 0.4 ml/min flow 
rate by a 36 min linear gradient of 5–50 % acetonitrile in 
H2O with 0.1 % formic acid (v/v). The UPLC was coupled 
with a triple quadrupole mass spectrometer equipped 
with a nano-LC electrospray ionization source (QTrap 
5500, ABSciex, Forster City, CA, USA) that was operated 
in positive ion mode. For the validation process, the dwell 
time of each transition was set at 25 ms and a maximum 
of 50 transitions were scanned in one run. The resolu-
tion of Q1 and Q3 were both set at High and the entrance 
and collision cell exit potential were set at 10 and 30  V 
respectively. The ion spray voltage was set at 5500 V. Data 
acquisition was set to scheduled SRM, with a target win-
dow of 120 s and target scan time 1.5 s.
Proteomics data analysis
SRM data analysis
Raw data were processed with Skyline v2.6 (http://pro-
teome.gs.washington.edu/software/skyline/) and transi-
tion peak areas were exported after manual inspection 
and curation of the traces. Peptides were quantified 
by summing the integrated peak areas of three transi-
tions. Protein abundance was quantified by summing 
the peptide abundances for that protein. Normalization 
for unequal amounts of protein loading was performed 
by selecting two housekeeping proteins (Pnp and TufB) 
from the SWATH dataset for which the abundance cor-
related strongly (r2 ≥  0.945) with the sum of total inte-
grated peak areas per sample. SRMs were developed for 
one peptide each and used to calculate a normalization 
factor that was applied to all other measured peak areas 
(Additional files 2, 4).
SWATH data bioinformatics analysis
MS/MS data from IDA and fractionated IDA were ana-
lyzed using the Paragon Algorithm from ProteinPilot 
v4.5 (ABSciex, Forster City, CA, USA). The 12 fractions 
from the fractionated IDA were analyzed simultane-
ously using ProteinPilot. Protein sequences for E. coli 
K-12 MG1655 were downloaded from NCBI Reference 
Sequence NC_000913.3 and Idi(Hp) and CrtE, CrtI and 
CrtB encoded on pAC-LYC04 were added to the .fasta 
file manually. Search parameters included trypsin diges-
tion, IAA as cys-alkylation, FDR analysis and ‘thorough’ 
settings. Criteria for including proteins in the statistical 
analysis were identification of  ≥3 peptides with  ≥95  % 
confidence score and an unused score higher than the 
5 % local false discovery rate score of all identified pro-
teins. MS/MS data from SWATH was analyzed and 
quantified using PeakView v.1.2 (ABSciex, Forster City, 
CA, USA). Analysis was performed using the pooled 
sample (ProGroup output from ProteinPilot) as the spec-
tra library for protein identification, containing 1126 
proteins. A maximum of 5 peptides per protein and 10 
transitions per peptide were used. Peptide modification 
was not allowed and shared peptides were excluded. Only 
peptides with 95 % confidence were used. An extraction 
window of 2 min was used.
Statistical analysis
SWATH protein output data from PeakView analysis 
was log2-transformed, quantile normalized and techni-
cal replicates were averaged. Statistical analysis of these 
data (three biological replicates per condition) was per-
formed using the R (http://www.R-project.org) package 
‘limma’ by fitting the data for each protein to a linear 
model, using a moderated t-statistic (adjusting results 
using empirical Bayes method) and adjusting for multiple 
testing (Benjamini-Hochberg). Proteins were classified 
as differentially expressed if the adjusted p value (Benja-
mini-Hochberg) was lower than 0.05.
Gene set enrichment analysis
Gene set enrichment analysis (GSEA) was performed 
using the ‘piano’ package in R. The list of gene level sta-
tistics generated with ‘limma’ was used as input for the 
runGSA function, using p-values and fold-changes for 
each gene. Annotation files for GO terms in E. coli K-12 
were downloaded from http://www.geneontology.org. 
The network plot in Fig. 2b was generated using distinct-
directional regulation (both directions) and a gene set p 
values ≤0.05. Alternative GSA methods were tested, but 
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no other significantly enriched GO terms were found 
with p ≤ 0.05.
ROS measurement
Flow cytometry analysis was performed using the 
H2O2-activated fluorescent dye dihydrorhodamine 123 
(DHR123). Strains MG* and Seq+ (without plasmids) 
were grown in LB medium to stationary phase, then 
diluted to a starting OD600 of 0.1. At 2, 4 and 6  h after 
inoculation, 20  µl were transferred to a 96-well micro-
titre plate and DHR was added to a final concentration 
of 0.5 mM. After ca. 2 h cells were diluted 1:20 in phos-
phate-buffered saline (PBS) and fluorescence was imme-
diately measured in an Accuri C6 flow cytometer (BD 
Biosciences). FL1-A fluorescence was measured for at 
least 10,000 events per sample with a flow rate of 14 µl/s, 
a threshold on FSC-H of 20,000 and no gating.
Induction of intracellular ROS by menadione
E. coli strain Seq+  harboring pAC-LYC04 was grown 
in LB medium containing 34  μg chloramphenicol/ml; 
100  µg ampicillin/ml was added for strains also har-
boring pT-dxs. Precultures were started from a single 
colony in 5  ml medium and were grown to stationary 
phase. A 1:100 dilution was used to inoculate 2  ml of 
fresh medium. Cells were grown in 24 deep-well plates 
(LifeTechnologies, cat no. CS15124) at 30 °C and 250 rpm 
orbital shaking. At an OD600 of 1–2, menadione was 
added at the indicated concentrations and cells were 
grown for 24 h before lycopene and final optical density 
were measured.
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